Desnitazene
| Desnitazene | |
|---|---|
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 307.4 g/mol [1] |
| Predicted LogP | 4.1 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C20H25N3 [1] |
| IUPAC name | 2-(2-benzylbenzimidazol-1-yl)-N,N-diethylethanamine [1] |
| SMILES | CCN(CC)CCN1C2=CC=CC=C2N=C1CC3=CC=CC=C3 [1] |
| InChI | InChI=1S/C20H25N3/c1-3-22(4-2)14-15-23-19-13-9-8-12-18(19)21-20(23)16-17-10-6-5-7-11-17/h5-13H,3-4,14-16H2,1-2H3 [1] |
| InChIKey | SLARNFUTJISNHU-UHFFFAOYSA-N [1] |
Desnitazene (also known as 1-Diethylaminoethyl-2-benzyl-benzimidazole, (2-(2-Benzyl-benzoimidazol-1-yl)-ethyl)-diethyl-amine, 2-Benzyl-1-(2-(diethylamino)ethyl)benzimidazole, Benzimidazole, 2-benzyl-1-(2-(diethylamino)ethyl)-, N,N-Diethyl-2-(phenylmethyl)-1H-benzimidazole-1-ethanamine, 1H-Benzimidazole-1-ethanamine, N,N-diethyl-2-(phenylmethyl)-, Oprea1_668421, Oprea1_819941, N-[2-(2-benzyl-1H-benzimidazol-1-yl)ethyl]-N,N-diethylamine or STK053382) is a opioid substance of the nitazene class.
Chemistry
Stereochemistry []
Desnitazene is a achiral mixture.
Subjective effects []
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 28787, Desnitazene. Accessed June 7, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/28787
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Desnitazene. UNII: RL4C6UA9R2. Global Substance Registration System. Accessed June 7, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/RL4C6UA9R2